CORRELATION BETWEEN CUMULATIVE METHOTREXATE DOSE, METABOLIC SYNDROME AND HEPATIC FIBROSIS DETECTED BY FIBROSCAN IN PATIENTS RECEIVING METHOTREXATE IN RHEUMATOID ARTHRITIS IN COMPARISON WITH PSORIATIC ARTHRITIS

被引：0
|
作者：
Lertnawapan, R. [1 ]
Chonprasertsuk, S. [1 ]
Siramolpiwat, S. [1 ]
Jatuworapruk., K. [1 ]
机构：
[1] Thammasat Univ, Fac Med, Internal Med, Pthumthani, Thailand
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2024年 / 83卷
关键词：
Comorbidities; Disease-modifying Drugs (DMARDs); Safety;
D O I：
10.1136/annrheumdis-2024-eular.2747
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0590
引用
收藏
页数：2
相关论文
共 50 条
  • [21] CIRRHOSIS IN PATIENTS WITH RHEUMATOID-ARTHRITIS RECEIVING LOW-DOSE METHOTREXATE
    CHANDRAN, G
    AHERN, MJ
    HALL, PDM
    GEDDES, R
    SMITH, MD
    HILL, W
    HARLEY, JH
    BRITISH JOURNAL OF RHEUMATOLOGY, 1994, 33 (10): : 981 - 984
  • [22] METHOTREXATE-INDUCED HEPATIC-FIBROSIS IN PATIENTS WITH RHEUMATOID-ARTHRITIS
    POLISSON, R
    SHERGY, W
    RICE, J
    CALDWELL, D
    ALLEN, N
    CLINICAL RESEARCH, 1988, 36 (03): : A535 - A535
  • [23] The time course of gastric methotrexate intolerance in patients with rheumatoid arthritis and psoriatic arthritis
    Dalkilic, Ediz
    Sahbazlar, Mustafa
    Gullulu, Mustafa
    Yavuz, Mahmut
    Dilek, Kamil
    Ersoy, Alpaslan
    Ozkaya, Guven
    Yurtkuran, Mustafa
    MODERN RHEUMATOLOGY, 2013, 23 (03) : 525 - 528
  • [24] Methotrexate Reduces the Frequency of Prediabetes in Patients with Rheumatoid Arthritis or Psoriatic Arthritis.
    Perdan-Pirkmajer, Katja
    Pirkmajer, Sergej
    Hocevar, Alojzija
    Rotar, ZIga
    Gaspersic, Natasa
    Praprotnik, Sonja
    Tomsic, Matija
    Ambrozic, Ales
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S223 - S223
  • [25] Liver Fibrosis in Rheumatoid Arthritis Patients Treated with Methotrexate
    Hilal, Ghizlane
    Akasbi, Nessrine
    Boudouaya, Hanae
    Salma, Ksir
    Harzy, Taoufik
    CURRENT RHEUMATOLOGY REVIEWS, 2020, 16 (04) : 293 - 297
  • [26] Comment on: Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy
    Boffa, Michael J.
    Smith, Alexander
    Chalmers, Robert J. G.
    RHEUMATOLOGY, 2009, 48 (11) : 1464 - 1464
  • [27] Comment on: Liver fibrosis in patients with psoriasis and psoriatic arthritis on long term, high cumulative dose methotrexate therapy: reply
    Lindsay, Karen
    Gough, Andrew
    Layton, Alison
    Fraser, Sandy
    RHEUMATOLOGY, 2009, 48 (11) : 1465 - 1465
  • [28] Methotrexate use and liver outcomes in psoriasis and rheumatoid arthritis patients: A commentary on "Risk of liver disease in patients with psoriasis, psoriatic arthritis and rheumatoid arthritis receiving methotrexate: A population-based study''
    Gau, Shuo-Yan
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (06) : E399 - E400
  • [29] TREATMENT OUTCOMES BASED ON METHOTREXATE DOSE RANGE IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING ETANERCEPT PLUS METHOTREXATE VERSUS METHOTREXATE ALONE
    Fleischmann, R.
    Koenig, A.
    Pederson, R.
    Ferdousi, T.
    Bananis, E.
    INTERNAL MEDICINE JOURNAL, 2012, 42 : 13 - 13
  • [30] Methotrexate treatment in early psoriatic arthritis in comparison to rheumatoid arthritis: an observational nationwide study
    Lindstrom, Ulf
    di Giuseppe, Daniela
    Exarchou, Sofia
    Alenius, Gerd-Marie
    Olofsson, Tor
    Klingberg, Eva
    Jacobsson, Lennart
    Askling, Johan
    Wallman, Johan K.
    RMD OPEN, 2023, 9 (02):
12345